Cholangiocarcinomas Not Yet Recruiting Phase 1 Trials for Cetuximab (DB00002)

Also known as: Cholangiocarcinoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract

IndicationStatusPhase
DBCOND0051818 (Cholangiocarcinomas)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03829436TPST-1120 as Monotherapy and in Combination With (Nivolumab, Docetaxel or Cetuximab) in Subjects With Advanced CancersTreatment